Loading…
In Vitro Models of Angiogenesis
Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex...
Saved in:
Published in: | World journal of surgery 2007-04, Vol.31 (4), p.654-663 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893 |
---|---|
cites | cdi_FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893 |
container_end_page | 663 |
container_issue | 4 |
container_start_page | 654 |
container_title | World journal of surgery |
container_volume | 31 |
creator | Ucuzian, Areck A. Greisler, Howard P. |
description | Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex cell–cell and cell‐extracellular matrix (ECM) interactions contribute to this process, leading finally to a network of tube‐like formations of endothelial cells supported by surrounding mural cells. The study of angiogenesis has broad clinical implications in the fields of peripheral and coronary vascular disease, oncology, hematology, wound healing, dermatology, and ophthalmology, among others. As such, novel, clinically relevant models of angiogenesis in vitro are crucial to the understanding of angiogenic processes. We highlight some of the advances made in the development of these models, and discuss the importance of incorporating the three‐dimensional cell‐matrix and EC–mural cell interactions into these in vitro assays of angiogenesis. This review also discusses our own 3‐D angiogenesis assay and some of the in vitro results from our lab as they relate to therapeutic neovascularization and tissue engineering of vascular grafts. |
doi_str_mv | 10.1007/s00268-006-0763-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70309172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1247171591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRbK3-AC9aBL1FZ2c3u9mjih-VioeKHpfsZlZS0qRmLdJ_b0oDghdPM4fnfWd4GDvmcMkB9FUEQJUlACoBrUQid9iQS4EJChS7bAhCyW7nYsAOYpwDcK1A7bMB10KjUumQnU7q8Vv51Tbj56agKo6bML6uP8rmg2qKZTxkeyGvIh31c8Rm93evt4_J9OVhcns9TbzUiEluMHVUUJBZGhxqSZn2RfBowAuQ6BxRII-YgswLWTjpQDjhHWUhM2LELraty7b5XFH8sosyeqqqvKZmFa0GAYZr7MCzP-C8WbV195lFbozEDDdtfAv5tomxpWCXbbnI27XlYDfi7Fac7cTZjTgru8xJX7xyCyp-E72pDjjvgTz6vAptXvsy_nKZ0gbNhjNb7rusaP3_Zfv-NLu5ByEyFD9eHoS0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219942829</pqid></control><display><type>article</type><title>In Vitro Models of Angiogenesis</title><source>Springer Link</source><creator>Ucuzian, Areck A. ; Greisler, Howard P.</creator><creatorcontrib>Ucuzian, Areck A. ; Greisler, Howard P.</creatorcontrib><description>Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex cell–cell and cell‐extracellular matrix (ECM) interactions contribute to this process, leading finally to a network of tube‐like formations of endothelial cells supported by surrounding mural cells. The study of angiogenesis has broad clinical implications in the fields of peripheral and coronary vascular disease, oncology, hematology, wound healing, dermatology, and ophthalmology, among others. As such, novel, clinically relevant models of angiogenesis in vitro are crucial to the understanding of angiogenic processes. We highlight some of the advances made in the development of these models, and discuss the importance of incorporating the three‐dimensional cell‐matrix and EC–mural cell interactions into these in vitro assays of angiogenesis. This review also discusses our own 3‐D angiogenesis assay and some of the in vitro results from our lab as they relate to therapeutic neovascularization and tissue engineering of vascular grafts.</description><identifier>ISSN: 0364-2313</identifier><identifier>EISSN: 1432-2323</identifier><identifier>DOI: 10.1007/s00268-006-0763-4</identifier><identifier>PMID: 17372665</identifier><identifier>CODEN: WJSUDI</identifier><language>eng</language><publisher>New York: Springer‐Verlag</publisher><subject>Angiogenesis Inhibitors - pharmacology ; Angiogenesis Model ; Animals ; Biological and medical sciences ; Fibroblast Growth Factor ; General aspects ; Growth Factor Delivery ; Humans ; Intercellular Signaling Peptides and Proteins - pharmacology ; Medical sciences ; Models, Biological ; Mural Cell ; Neovascularization, Pathologic - drug therapy ; Neovascularization, Pathologic - physiopathology ; Neovascularization, Physiologic - drug effects ; Neovascularization, Physiologic - physiology ; Tissue Engineering - methods ; Vascular Diseases - therapy ; Vascular Endothelial Growth Factor</subject><ispartof>World journal of surgery, 2007-04, Vol.31 (4), p.654-663</ispartof><rights>2007 The Author(s) under exclusive licence to Société Internationale de Chirurgie</rights><rights>2007 INIST-CNRS</rights><rights>Société Internationale de Chirurgie 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893</citedby><cites>FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18679295$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17372665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ucuzian, Areck A.</creatorcontrib><creatorcontrib>Greisler, Howard P.</creatorcontrib><title>In Vitro Models of Angiogenesis</title><title>World journal of surgery</title><addtitle>World J Surg</addtitle><description>Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex cell–cell and cell‐extracellular matrix (ECM) interactions contribute to this process, leading finally to a network of tube‐like formations of endothelial cells supported by surrounding mural cells. The study of angiogenesis has broad clinical implications in the fields of peripheral and coronary vascular disease, oncology, hematology, wound healing, dermatology, and ophthalmology, among others. As such, novel, clinically relevant models of angiogenesis in vitro are crucial to the understanding of angiogenic processes. We highlight some of the advances made in the development of these models, and discuss the importance of incorporating the three‐dimensional cell‐matrix and EC–mural cell interactions into these in vitro assays of angiogenesis. This review also discusses our own 3‐D angiogenesis assay and some of the in vitro results from our lab as they relate to therapeutic neovascularization and tissue engineering of vascular grafts.</description><subject>Angiogenesis Inhibitors - pharmacology</subject><subject>Angiogenesis Model</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Fibroblast Growth Factor</subject><subject>General aspects</subject><subject>Growth Factor Delivery</subject><subject>Humans</subject><subject>Intercellular Signaling Peptides and Proteins - pharmacology</subject><subject>Medical sciences</subject><subject>Models, Biological</subject><subject>Mural Cell</subject><subject>Neovascularization, Pathologic - drug therapy</subject><subject>Neovascularization, Pathologic - physiopathology</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Neovascularization, Physiologic - physiology</subject><subject>Tissue Engineering - methods</subject><subject>Vascular Diseases - therapy</subject><subject>Vascular Endothelial Growth Factor</subject><issn>0364-2313</issn><issn>1432-2323</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkE1Lw0AQhhdRbK3-AC9aBL1FZ2c3u9mjih-VioeKHpfsZlZS0qRmLdJ_b0oDghdPM4fnfWd4GDvmcMkB9FUEQJUlACoBrUQid9iQS4EJChS7bAhCyW7nYsAOYpwDcK1A7bMB10KjUumQnU7q8Vv51Tbj56agKo6bML6uP8rmg2qKZTxkeyGvIh31c8Rm93evt4_J9OVhcns9TbzUiEluMHVUUJBZGhxqSZn2RfBowAuQ6BxRII-YgswLWTjpQDjhHWUhM2LELraty7b5XFH8sosyeqqqvKZmFa0GAYZr7MCzP-C8WbV195lFbozEDDdtfAv5tomxpWCXbbnI27XlYDfi7Fac7cTZjTgru8xJX7xyCyp-E72pDjjvgTz6vAptXvsy_nKZ0gbNhjNb7rusaP3_Zfv-NLu5ByEyFD9eHoS0</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>Ucuzian, Areck A.</creator><creator>Greisler, Howard P.</creator><general>Springer‐Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200704</creationdate><title>In Vitro Models of Angiogenesis</title><author>Ucuzian, Areck A. ; Greisler, Howard P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Angiogenesis Inhibitors - pharmacology</topic><topic>Angiogenesis Model</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Fibroblast Growth Factor</topic><topic>General aspects</topic><topic>Growth Factor Delivery</topic><topic>Humans</topic><topic>Intercellular Signaling Peptides and Proteins - pharmacology</topic><topic>Medical sciences</topic><topic>Models, Biological</topic><topic>Mural Cell</topic><topic>Neovascularization, Pathologic - drug therapy</topic><topic>Neovascularization, Pathologic - physiopathology</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Neovascularization, Physiologic - physiology</topic><topic>Tissue Engineering - methods</topic><topic>Vascular Diseases - therapy</topic><topic>Vascular Endothelial Growth Factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ucuzian, Areck A.</creatorcontrib><creatorcontrib>Greisler, Howard P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ucuzian, Areck A.</au><au>Greisler, Howard P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vitro Models of Angiogenesis</atitle><jtitle>World journal of surgery</jtitle><addtitle>World J Surg</addtitle><date>2007-04</date><risdate>2007</risdate><volume>31</volume><issue>4</issue><spage>654</spage><epage>663</epage><pages>654-663</pages><issn>0364-2313</issn><eissn>1432-2323</eissn><coden>WJSUDI</coden><abstract>Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex cell–cell and cell‐extracellular matrix (ECM) interactions contribute to this process, leading finally to a network of tube‐like formations of endothelial cells supported by surrounding mural cells. The study of angiogenesis has broad clinical implications in the fields of peripheral and coronary vascular disease, oncology, hematology, wound healing, dermatology, and ophthalmology, among others. As such, novel, clinically relevant models of angiogenesis in vitro are crucial to the understanding of angiogenic processes. We highlight some of the advances made in the development of these models, and discuss the importance of incorporating the three‐dimensional cell‐matrix and EC–mural cell interactions into these in vitro assays of angiogenesis. This review also discusses our own 3‐D angiogenesis assay and some of the in vitro results from our lab as they relate to therapeutic neovascularization and tissue engineering of vascular grafts.</abstract><cop>New York</cop><pub>Springer‐Verlag</pub><pmid>17372665</pmid><doi>10.1007/s00268-006-0763-4</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-2313 |
ispartof | World journal of surgery, 2007-04, Vol.31 (4), p.654-663 |
issn | 0364-2313 1432-2323 |
language | eng |
recordid | cdi_proquest_miscellaneous_70309172 |
source | Springer Link |
subjects | Angiogenesis Inhibitors - pharmacology Angiogenesis Model Animals Biological and medical sciences Fibroblast Growth Factor General aspects Growth Factor Delivery Humans Intercellular Signaling Peptides and Proteins - pharmacology Medical sciences Models, Biological Mural Cell Neovascularization, Pathologic - drug therapy Neovascularization, Pathologic - physiopathology Neovascularization, Physiologic - drug effects Neovascularization, Physiologic - physiology Tissue Engineering - methods Vascular Diseases - therapy Vascular Endothelial Growth Factor |
title | In Vitro Models of Angiogenesis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T19%3A57%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vitro%20Models%20of%20Angiogenesis&rft.jtitle=World%20journal%20of%20surgery&rft.au=Ucuzian,%20Areck%20A.&rft.date=2007-04&rft.volume=31&rft.issue=4&rft.spage=654&rft.epage=663&rft.pages=654-663&rft.issn=0364-2313&rft.eissn=1432-2323&rft.coden=WJSUDI&rft_id=info:doi/10.1007/s00268-006-0763-4&rft_dat=%3Cproquest_cross%3E1247171591%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=219942829&rft_id=info:pmid/17372665&rfr_iscdi=true |